For decades now, we have been able to offer anti-VEGF treatments to patients with wet AMD. Yet for dry AMD, there have been few options we can recommend to our patients outside of AREDS formulations and lifestyle modifications. But with newer scientific advances, there are indeed new classes of injectable medications that are now being offered to some patients wtih dry AMD. Retinal specialist Dr. Ashkan Abbey joins the podcast to share the latest research.
This episode is sponsored by Thea Pharma Canada - https://www.theapharma.ca
Podden och tillhörande omslagsbild på den här sidan tillhör
Zale Mednick. Innehållet i podden är skapat av Zale Mednick och inte av,
eller tillsammans med, Poddtoppen.